A miR-31 transgenic mouse has increased lung hyperplasia, adenoma, and adenocarcinoma and promotes KRAS mediated oncogenesis by directly reducing expression of negative regulators of RAS/MAPK signaling26. The gene discussed is KRAS; the disease is adenocarcinoma.